Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
McKesson
Harvard Business School
Moodys

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 4,517,288

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 4,517,288
Title: Solid phase system for ligand assay
Abstract:A method for conducting a ligand assay in an inert porous medium wherein a binding material is immunologically immobilized within the medium, which includes the steps of immunologically immobilizing a binding material within a finite zone of the medium, applying an analyte to the zone containing the immobilized binding material, applying a labeled indicator to the zone which becomes immobilized within the zone in an amount which can be correlated to the amount of analyte in the zone, applying a solvent to substantially the center of the zone to chromatographically separate the unbound labeled indicator from the zone, and measuring the amount of labeled indicator remaining in the zone.
Inventor(s): Giegel; Joseph L. (Miami, FL), Brotherton; Mary M. (Miami, FL)
Assignee: American Hospital Supply Corp. (Evanston, IL)
Application Number:06/227,664
Patent Claims:see list of patent claims

Details for Patent 4,517,288

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Csl Behring Ag CARIMUNE, CARIMUNE NF, PANGLOBULIN, SANDOGLOBULIN immune globulin intravenous (human) For Injection 102367 2000-07-27 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2007-07-26 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2009-10-02 ⤷  Try it Free 2040-01-28
Csl Behring Ag PRIVIGEN immune globulin intravenous (human), 10% liquid Injection 125201 2013-02-07 ⤷  Try it Free 2040-01-28
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2009-09-17 ⤷  Try it Free 2040-01-28
Bio Products Laboratory GAMMAPLEX immune globulin intravenous (human) Injection 125329 2017-02-06 ⤷  Try it Free 2040-01-28
Csl Behring Ag HIZENTRA immune globulin subcutaneous (human), 20% liquid Injection 125350 2010-03-04 ⤷  Try it Free 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Harvard Business School
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.